LymphedemaV1, Main, Exploration, bibRecord, 002349

Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.

Identifieur interne : 002349 ( Main/Exploration ); précédent : 002348; suivant : 002350

Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.

Auteurs : Nadeem R. Abu-Rustum

Source :

The journal of obstetrics and gynaecology research [ 1447-0756 ] ; 2014.

RBID : pubmed:24620369

Descripteurs français

KwdFr :
- Agents colorants, Algorithmes, Aorte, Femelle, Humains, Lymphadénectomie, Métastase lymphatique, Noeuds lymphatiques (anatomopathologie), Noeuds lymphatiques (imagerie diagnostique), Pelvis, Radiopharmaceutiques, Scintigraphie, Stade de la tumeur, Tumeurs de l'endomètre (), Tumeurs de l'endomètre (anatomopathologie).
MESH :
- anatomopathologie : Noeuds lymphatiques, Tumeurs de l'endomètre.
- imagerie diagnostique : Noeuds lymphatiques.
- Agents colorants, Algorithmes, Aorte, Femelle, Humains, Lymphadénectomie, Métastase lymphatique, Pelvis, Radiopharmaceutiques, Scintigraphie, Stade de la tumeur, Tumeurs de l'endomètre.

English descriptors

KwdEn :
- Algorithms, Aorta, Coloring Agents, Endometrial Neoplasms (pathology), Endometrial Neoplasms (surgery), Female, Humans, Lymph Node Excision, Lymph Nodes (diagnostic imaging), Lymph Nodes (pathology), Lymphatic Metastasis, Neoplasm Staging, Pelvis, Radionuclide Imaging, Radiopharmaceuticals.
MESH :
- chemical : Coloring Agents, Radiopharmaceuticals.
- diagnostic imaging : Lymph Nodes.
- pathology : Endometrial Neoplasms, Lymph Nodes.
- surgery : Endometrial Neoplasms.
- Algorithms, Aorta, Female, Humans, Lymph Node Excision, Lymphatic Metastasis, Neoplasm Staging, Pelvis, Radionuclide Imaging.

Abstract

Endometrial cancer is the most common gynecologic malignancy. In the majority of patients, the disease will present at an early stage, without metastasis, and with an excellent prognosis. Although the rate of metastasis in patients with early stage endometrial cancer is low, the standard of treatment still includes a complete or selective pelvic and para-aortic lymphadenectomy for staging. Many patients will undergo a comprehensive lymphadenectomy despite having disease confined to the uterus, resulting in detrimental side-effects, including lower extremity lymphedema. Recent studies, such as 'A Study in the Treatment of Endometrial Cancer', have shown that there is no therapeutic benefit to a complete lymphadenectomy in early stage endometrial cancer, although further study is needed to confirm these findings. The use of sentinel lymph node (SLN) mapping in endometrial cancer may provide an appropriate middle ground between the two schools of thought of complete lymphadenectomy versus no nodal evaluation. SLN mapping, which is gaining ever-increasing acceptance in many cancer types, is based on the concept that lymph node metastasis is the result of an orderly process, that is, the lymph drains in a specific pattern away from the tumor, and therefore if the SLN, or first node, is negative for metastasis, then the nodes after the SLN should also be negative. We present here the Memorial Sloan-Kettering Cancer Center experience with SLN mapping in uterine cancer, a technique we first began using in 2003 and have improved over the years.

PubMed: 24620369

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.</title>
<author><name sortKey="Abu Rustum, Nadeem R" sort="Abu Rustum, Nadeem R" uniqKey="Abu Rustum N" first="Nadeem R" last="Abu-Rustum">Nadeem R. Abu-Rustum</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24620369</idno>
<idno type="pmid">24620369</idno>
<idno type="wicri:Area/PubMed/Corpus">001627</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001627</idno>
<idno type="wicri:Area/PubMed/Curation">001627</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001627</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001627</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001627</idno>
<idno type="wicri:Area/Ncbi/Merge">006415</idno>
<idno type="wicri:Area/Ncbi/Curation">006415</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006415</idno>
<idno type="wicri:Area/Main/Merge">002352</idno>
<idno type="wicri:Area/Main/Curation">002349</idno>
<idno type="wicri:Area/Main/Exploration">002349</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.</title>
<author><name sortKey="Abu Rustum, Nadeem R" sort="Abu Rustum, Nadeem R" uniqKey="Abu Rustum N" first="Nadeem R" last="Abu-Rustum">Nadeem R. Abu-Rustum</name>
</author>
</analytic>
<series><title level="j">The journal of obstetrics and gynaecology research</title>
<idno type="eISSN">1447-0756</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithms</term>
<term>Aorta</term>
<term>Coloring Agents</term>
<term>Endometrial Neoplasms (pathology)</term>
<term>Endometrial Neoplasms (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymph Nodes (diagnostic imaging)</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphatic Metastasis</term>
<term>Neoplasm Staging</term>
<term>Pelvis</term>
<term>Radionuclide Imaging</term>
<term>Radiopharmaceuticals</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agents colorants</term>
<term>Algorithmes</term>
<term>Aorte</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Métastase lymphatique</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Noeuds lymphatiques (imagerie diagnostique)</term>
<term>Pelvis</term>
<term>Radiopharmaceutiques</term>
<term>Scintigraphie</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de l'endomètre ()</term>
<term>Tumeurs de l'endomètre (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term>
<term>Radiopharmaceuticals</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Noeuds lymphatiques</term>
<term>Tumeurs de l'endomètre</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Noeuds lymphatiques</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Endometrial Neoplasms</term>
<term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Endometrial Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Algorithms</term>
<term>Aorta</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymphatic Metastasis</term>
<term>Neoplasm Staging</term>
<term>Pelvis</term>
<term>Radionuclide Imaging</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Agents colorants</term>
<term>Algorithmes</term>
<term>Aorte</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Métastase lymphatique</term>
<term>Pelvis</term>
<term>Radiopharmaceutiques</term>
<term>Scintigraphie</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de l'endomètre</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Endometrial cancer is the most common gynecologic malignancy. In the majority of patients, the disease will present at an early stage, without metastasis, and with an excellent prognosis. Although the rate of metastasis in patients with early stage endometrial cancer is low, the standard of treatment still includes a complete or selective pelvic and para-aortic lymphadenectomy for staging. Many patients will undergo a comprehensive lymphadenectomy despite having disease confined to the uterus, resulting in detrimental side-effects, including lower extremity lymphedema. Recent studies, such as 'A Study in the Treatment of Endometrial Cancer', have shown that there is no therapeutic benefit to a complete lymphadenectomy in early stage endometrial cancer, although further study is needed to confirm these findings. The use of sentinel lymph node (SLN) mapping in endometrial cancer may provide an appropriate middle ground between the two schools of thought of complete lymphadenectomy versus no nodal evaluation. SLN mapping, which is gaining ever-increasing acceptance in many cancer types, is based on the concept that lymph node metastasis is the result of an orderly process, that is, the lymph drains in a specific pattern away from the tumor, and therefore if the SLN, or first node, is negative for metastasis, then the nodes after the SLN should also be negative. We present here the Memorial Sloan-Kettering Cancer Center experience with SLN mapping in uterine cancer, a technique we first began using in 2003 and have improved over the years.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Abu Rustum, Nadeem R" sort="Abu Rustum, Nadeem R" uniqKey="Abu Rustum N" first="Nadeem R" last="Abu-Rustum">Nadeem R. Abu-Rustum</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002349 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002349 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24620369
   |texte=   Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24620369" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.

Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.